Harvard Professor Tarun Khanna to joins former Ranbaxy CEOs GVK BIO board

The move marks a trend of senior academicians from leading institutes like Harvard and Kellogg joining the board of Indian companies.

Dr.Tarun Khanna is the Jorge Paulo Lemann Professor at the Harvard Business School, where he has been a member of the Strategy group since 1993. He holds a BS degree from Princeton University and a Ph.D. from Harvard University. Dr.Khanna heads the Strategy course in the Harvard MBA program and the Strategy, Leadership & Governance Executive Education program.

We are very excited that Tarun has joined our Board of Directors. Taruns vast experience in global strategy and understanding of the emerging markets will facilitate GVK BIO to grow to the next level , said Mr. D S Brar, Chairman, GVK Biosciences. Mr Brar is credited with leading pharma major Ranbaxy into a global player.

Dr.Tarun Khanna said that, I am pleased to join the GVK Biosciences Board of Directors at this exciting time of the Company and Industry and I look forward to this association. GVK Biosciences delivers integrated research services to big Pharma and Biotech companies globally. The company accelerates the Drug Discovery and Development process of its customers through science and innovation. Currently the company has more than 1,300 employees spread across facilities in Hyderabad, Chennai, Mumbai and Gurgaon.